Jazz Pharmaceuticals plc
NASDAQ:JAZZ
110.45 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,834.204 | 3,659.374 | 3,094.238 | 2,363.567 | 2,161.761 | 1,890.922 | 1,618.693 | 1,487.973 | 1,324.803 | 1,172.875 | 872.423 | 585.979 | 272.277 | 173.781 | 128.449 | 67.514 | 65.303 | 44.856 | 21.442 | 0 |
| Cost of Revenue
| 1,043.861 | 540.517 | 440.76 | 148.917 | 127.93 | 121.544 | 110.188 | 105.386 | 102.526 | 117.418 | 102.146 | 78.425 | 13.942 | 13.559 | 9.638 | 13.924 | 8.903 | 6.968 | 4.292 | 0 |
| Gross Profit
| 2,790.343 | 3,118.857 | 2,653.478 | 2,214.65 | 2,033.831 | 1,769.378 | 1,508.505 | 1,382.587 | 1,222.277 | 1,055.457 | 770.277 | 507.554 | 258.335 | 160.222 | 118.811 | 53.59 | 56.4 | 37.888 | 17.15 | 0 |
| Gross Profit Ratio
| 0.728 | 0.852 | 0.858 | 0.937 | 0.941 | 0.936 | 0.932 | 0.929 | 0.923 | 0.9 | 0.883 | 0.866 | 0.949 | 0.922 | 0.925 | 0.794 | 0.864 | 0.845 | 0.8 | 0 |
| Reseach & Development Expenses
| 849.658 | 590.453 | 505.748 | 335.375 | 299.726 | 226.616 | 198.442 | 162.297 | 135.253 | 85.181 | 46.62 | 20.477 | 14.12 | 25.612 | 36.561 | 69.963 | 69.792 | 54.956 | 45.783 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 380.414 | 303.303 | 223.182 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25.7 | 1 | 0.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,281.405 | 1,416.967 | 1,451.683 | 854.233 | 736.942 | 683.53 | 544.156 | 502.892 | 449.119 | 406.114 | 304.303 | 223.882 | 108.936 | 68.996 | 58.652 | 111.401 | 78.54 | 51.384 | 23.551 | 0 |
| Other Expenses
| 1,476.942 | 599.169 | 525.769 | 259.58 | 354.814 | 201.498 | 152.065 | 101.994 | 98.162 | 126.584 | 79.042 | 65.351 | 7.448 | 7.825 | 7.668 | 12.828 | 46.846 | 9.6 | 4.96 | -24.804 |
| Operating Expenses
| 2,131.063 | 2,606.589 | 2,483.2 | 1,449.188 | 1,391.482 | 1,111.644 | 894.663 | 767.183 | 682.534 | 617.879 | 429.965 | 309.71 | 130.504 | 102.433 | 102.881 | 194.192 | 195.178 | 115.94 | 74.294 | -24.804 |
| Operating Income
| 659.28 | 512.268 | 170.278 | 765.462 | 532.374 | 614.838 | 528.842 | 591.654 | 508.22 | 195.587 | 340.312 | 197.844 | 127.831 | 57.789 | 15.93 | -170.365 | -138.778 | -78.052 | -78.444 | -24.804 |
| Operating Income Ratio
| 0.172 | 0.14 | 0.055 | 0.324 | 0.246 | 0.325 | 0.327 | 0.398 | 0.384 | 0.167 | 0.39 | 0.338 | 0.469 | 0.333 | 0.124 | -2.523 | -2.125 | -1.74 | -3.658 | 0 |
| Total Other Income Expenses Net
| -361.351 | -885.052 | -283.116 | -490.367 | -78.072 | -51.196 | -94.969 | -21.016 | -46.893 | -233.308 | -5.446 | -3.62 | -1.247 | -12.289 | -0.004 | -25.829 | -29.972 | 30.483 | -22.201 | 0 |
| Income Before Tax
| 297.929 | -372.784 | -112.838 | 275.095 | 454.302 | 529.463 | 441.117 | 532.446 | 435.933 | 151.557 | 307.95 | 177.355 | 124.984 | 32.778 | -6.836 | -184.339 | -138.826 | -47.569 | -100.645 | 0 |
| Income Before Tax Ratio
| 0.078 | -0.102 | -0.036 | 0.116 | 0.21 | 0.28 | 0.273 | 0.358 | 0.329 | 0.129 | 0.353 | 0.303 | 0.459 | 0.189 | -0.053 | -2.73 | -2.126 | -1.06 | -4.694 | 0 |
| Income Tax Expense
| -119.912 | -158.645 | 216.116 | 33.517 | -73.154 | 80.162 | -47.74 | 135.236 | 106.399 | 94.231 | 91.638 | -83.794 | 2.847 | 25.011 | 22.766 | 43.737 | 0.048 | -18.661 | 28.012 | 24.804 |
| Net Income
| 414.832 | -214.139 | -328.954 | 238.616 | 523.367 | 447.098 | 487.848 | 396.831 | 329.535 | 58.387 | 216.312 | 288.586 | 124.984 | 32.778 | -6.836 | -184.339 | -138.826 | -59.391 | -85.156 | -24.804 |
| Net Income Ratio
| 0.108 | -0.059 | -0.106 | 0.101 | 0.242 | 0.236 | 0.301 | 0.267 | 0.249 | 0.05 | 0.248 | 0.492 | 0.459 | 0.189 | -0.053 | -2.73 | -2.126 | -1.324 | -3.971 | 0 |
| EPS
| 6.55 | -3.42 | -5.51 | 4.28 | 9.22 | 7.45 | 8.13 | 6.56 | 5.38 | 0.98 | 3.71 | 5.09 | 3.01 | 0.9 | -0.23 | -7.19 | -10.04 | -4.41 | -6.32 | -1.84 |
| EPS Diluted
| 6.1 | -3.42 | -5.51 | 4.22 | 9.09 | 7.3 | 7.96 | 6.41 | 5.23 | 0.93 | 3.51 | 4.79 | 2.67 | 0.83 | -0.23 | -7.19 | -10.04 | -4.41 | -6.32 | -1.84 |
| EBITDA
| 1,297.976 | 1,111.437 | 696.047 | 1,025.042 | 997.163 | 859.232 | 765.907 | 717.398 | 637.905 | 564.162 | 422.402 | 272.073 | 136.905 | 77.903 | 23.602 | -99.747 | -98.28 | -98.225 | -29.504 | -24.804 |
| EBITDA Ratio
| 0.339 | 0.304 | 0.225 | 0.434 | 0.461 | 0.454 | 0.473 | 0.482 | 0.482 | 0.481 | 0.484 | 0.464 | 0.503 | 0.448 | 0.184 | -1.477 | -1.505 | -2.19 | -1.376 | 0 |